Press release
Engaged in Sphingolipid Research? Check Out Echelon's New S1P antibody Z-P300!
Recently, scientific literature has suggested that S1P is a potent tumorigenic growth factor that is likely released from tumor cells and that S1P may be a novel biomarker for early stage cancer detection.
Sphingosine kinase has also been shown to be up-regulated in a variety of cancer types. S1P antibody (LT1002) was originally developed and patented at Lpath Therapeutics. Echelon Biosciences has further developed and validated the exciting new antibody Z-P300 for in vitro and cell-based applications.
Validated for use in:
IHC
ELISA
References
1) Visentin B, Reynolds G, Sabbadini R. (2012) Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples. Methods Mol Biol. 874:55-67.
2) O'Brien N, Jones ST, Williams DG, Cunningham HB, Moreno K, Visentin B, et al. (2009) Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J Lipid Res.;50(11):2245-57.
3) Swaney JS, Moreno KM, Gentile AM, Sabbadini RA, Stoller GL. (2008) Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Exp Eye Res.;87(4):367-75.
All Echelon products can be ordered from MoBiTec: http://www.mobitec.com
Contact info@mobitec.com for more information and bulk pricing options.
About MoBiTec GmbH
MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.
In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.
MoBiTec GmbH, Lotzestr. 22a, 37083 Goettingen,
Germany, info@mobitec.com, www.mobitec.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Engaged in Sphingolipid Research? Check Out Echelon's New S1P antibody Z-P300! here
News-ID: 1181053 • Views: …
More Releases from MoBiTec GmbH
FerroFarRed - An Ion Indicator for the Specific Detection of Fe2+
Intracellular Fe2+ can react with hydrogen peroxide, thereby producing the hydroxyl radical, a reactive oxygen species (ROS). Excessive ROS causes oxidative stress, resulting in cancer and neurodegenerative diseases.
FerroFarRed (also known as SiRhoNox-1 or ER-SiRhoNox) is a fluorescent probe,manufactured by Goryo Chemical, Japan, distributed in Europe by MoBiTec GmbH, Germany. FerroFarRed specifically detects labile iron (II) ions (Fe2+) and is known to react with Fe2+ only, separately from other metal…
TransIT-VirusGEN® Transfection Reagent - Ideal for Recombinant Adeno-associated …
TransIT-VirusGEN® Transfection Reagent by Mirus, USA, is designed to enhance delivery of packaging and transfer vectors to adherent and suspension HEK 293 cell types to increase recombinant adeno-associated virus (AAV) and lentivirus production.
Adeno-associated virus (AAV) is a nonenveloped, single stranded DNA virus from the Paroviridae family notable for its lack of pathogenicity, low immunogenicity and ability to infect both dividing and quiescent cells. Because AAV is replication-defective in the…
Elabscience's Vast Portfolio of Products for Life Science Research Distributed b …
MoBiTec's most recent select partner Elabscience specializes in immunodiagnostic technology for the life science community, offering a complete platform for R&D and manufacture.
Elabscience major products cover Proteins, Antibodies, ELlSA Kits, CLIA Kits, Labeling Kits，Biochemical Kits, Cell Lines, and Other Reagents.
Elabscience also offers custom services for customers, including Protein Expression and Purification Service, Custom Antibody Service, Custom ELISA Service, Cell Biology Service, Molecular Biology Service, and Whole Research Project Solutions.
Every…
MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, …
The "Potsdam Days on Bioanalysis" provide an excellent platform for researchers, clinicians, and entrepreneurs to discuss diagnostics' hot topics, trends, and recent developments as well as new areas of application and future markets.
Often, the implementation of goal-oriented and profitable cooperations is quite a challenge, in particular when it comes to innovative product developments in the fields of diagnostics and analytics. Typically, challenges lie within finding the right cooperation partners, identifying…
More Releases for S1P
New Report Explores Hottest Trends in Azithromycin Injection Market 2021-2025: G …
Overview of Global Azithromycin Injection Market:
This report provides in-depth study of “Global Azithromycin Injection Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Azithromycin Injection Market report also provides an in-depth survey of key players in the market organization.
As per the market research study, Azithromycin is a semi-synthetic macrolide antibiotic used for treating otitis media (middle ear infection), tonsillitis, laryngitis, bronchitis, pneumonia, and sinusitis…
S1P receptor modulator Drugs Market To Witness a Major Overhaul between 2020 and …
S1P receptor performs basic biological processes such as cell proliferation, migration, cytoskeleton organization, immune cell trafficking and others. S1P receptor modulators are a type of immunomodulatory used in case of multiple sclerosis, psoriasis, inflammatory diseases, and cancer. S1P receptor modulators are used to control the release of lymphocytes in peripheral blood and reach the central nervous system. According to the Multiple Sclerosis Association of America, approximately 3.5 out of 1,000…
Multiple Sclerosis Market Is Expected to Exhibit an Upward Growth Trend Across G …
ResearchMoz include new market research report "Multiple Sclerosis: Dynamic Market Forecast to 2026" to its huge collection of research reports.
Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape.
The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the MS space, including regulatory, commercial, and clinical events as well as understand how all of these events…
Multiple Sclerosis Global Key Players - Biogen, Merck KGaA, Teva, Sanofi, and No …
Multiple Sclerosis
Overview
Multiple Sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection, and neurodegeneration within the central nervous system. It is the most common cause of non-traumatic neurological disability in young adults, afflicting at least 2.5 million people worldwide.
In most patients, the disease is characterized initially by episodes of reversible neurological deficits, which is often followed by progressive neurological deterioration over time. The precise etiology of…
ISM at the A+A 2015 – The most safe of encounters
The trade fair appearance of ISM 2015 at the A+A with its two PPE-brands ALBATROS and PU-MA SAFETY is dedicated to new concepts, strong design and innovative products. Based on reliability and quality, ISM would like to expand its market leadership in safety- and work shoes with ALBATROS and PUMA SAFETY.
ALBATROS as well as PUMA SAFETY will present a broad product range at the A+A. There are hardly any…
Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific O …
Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas.
At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for…
